C07D 211/42
Attached in position 3 or 5
Official title: attached in position 3 or 5
C07D211/42 (Attached in position 3 or 5) appears on 350 US grants and 330 published applications in this corpus.
Search patents in C07D- Granted patents
- 350
- Published applications
- 330
- Assignees
- 233
- Inventors
- 1,370
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 6 | 0 |
| 1980 | 2 | 0 |
| 1981 | 10 | 0 |
| 1982 | 10 | 0 |
| 1983 | 12 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 5 | 0 |
| 1989 | 10 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 5 | 0 |
| 1994 | 5 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 9 | 0 |
| 2001 | 10 | 3 |
| 2002 | 9 | 13 |
| 2003 | 10 | 18 |
| 2004 | 6 | 15 |
| 2005 | 5 | 11 |
| 2006 | 8 | 18 |
| 2007 | 9 | 20 |
| 2008 | 9 | 13 |
| 2009 | 16 | 22 |
| 2010 | 13 | 13 |
| 2011 | 10 | 15 |
| 2012 | 13 | 9 |
| 2013 | 9 | 11 |
| 2014 | 13 | 12 |
| 2015 | 9 | 13 |
| 2016 | 3 | 10 |
| 2017 | 9 | 11 |
| 2018 | 6 | 12 |
| 2019 | 8 | 8 |
| 2020 | 8 | 8 |
| 2021 | 9 | 11 |
| 2022 | 7 | 17 |
| 2023 | 3 | 16 |
| 2024 | 5 | 13 |
| 2025 | 11 | 12 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof4 Aug 2026US 12,698,259 B2Dana-Farber Cancer Institute, Inc.
- Methods for separation and recovery of rare earth elements from aqueous solutions using diglycolamide derivatives30 Jun 2026US 12,668,857 B2Battelle Energy Alliance, LLC
- Ionizable lipids and compositions and uses thereof24 Mar 2026US 12,583,817 B2Massachusetts Institute of Technology
- Inhibitors of MLH1 and/or PMS2 for cancer treatment17 Feb 2026US 12,552,758 B2NeoPhore Limited
- Erap1 modulating compounds16 Jul 2026US 2026/0199455 A1Grey Wolf Therapeutics Limited
- Ionizable lipids and compositions and uses thereof2 Jul 2026US 2026/0184671 A1Massachusetts Institute of Technology
- Modulators of mas-related g-protein receptor x4 and related products and methods23 Apr 2026US 2026/0108482 A1Escient Pharmaceuticals, Inc.
- Compound or salt thereof and lipid particles16 Apr 2026US 2026/0102348 A1FUJIFILM Corporation
- Amino lipid compound and lipid nanoparticle for delivering bioactive ingredient5 Feb 2026US 2026/0035338 A1Shenzhen Shenxin Biotechnology Co., Ltd.
Most cited
By later US patents
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Method of treating addiction or dependence using a ligand for a monamine receptor or transporter67US 7,294,637 B2Sepracor Inc. · 2007
- 4H-1-benzopyran-4-one compounds which have anti-inflamatory or immunodulating action64US 4,900,727 AHoechst Aktiengesellschaft · 1990
- β2-adrenergic receptor agonists59US 6,541,669 B1Theravance, Inc. · 2003
- Materials and methods to potentiate cancer treatment55US 7,179,912 B2ICOS Corporation · 2007